NuGEN Technologies, Inc., a privately held company that develops and commercializes nucleic acid amplification and labeling systems announced today that it has received US Patent No. 7,402,386, “Global amplification using random priming by a composite primer.”
The patent describes a global whole genome amplification methodology using composite DNA/RNA primers able to anneal to multiple sites within the template polynucleotide. The resulting amplified nucleic acid is suitable for use with a wide array of analytical and investigative approaches and applications.
The details can be read here.
No comments:
Post a Comment